71
Views
9
CrossRef citations to date
0
Altmetric
Case Series

Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19

, , , , , ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 3123-3128 | Published online: 12 Jul 2021

References

  • Cheng C, Li C, Zhao T, et al. COVID-19 with rheumatic diseases: a report of 5 cases. Clin Rheumatol. 2020;39(7):2025–2029. doi:10.1007/s10067-020-05160-x
  • Nowak UM, Newkirk MM. Rheumatoid factors: good or bad for you? Int Arch Allergy Immunol. 2005;138(2):180–188. doi:10.1159/000088794
  • Zamora AC, Hoskote SS, Abascal-Bolado B, et al. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respir Med. 2016;118:39–45. doi:10.1016/j.rmed.2016.07.009
  • Nozue T, Toyoshima M, Fukada A, Suda T. Anti-Jo-1 antibody-positive interstitial pneumonia in an elderly patient with congenital rubella syndrome. Intern Med. 2019;58(14):2063–2066. doi:10.2169/internalmedicine.2454-18
  • Jeffrey T, Suren J, James B. A case of adult dermatomyositis associated with parainfluenza virus infection and Jo-1 antibody. Int J Rheum Dis. 2017;20.
  • Tillie-Leblond I, Wislez M, Valeyre D, et al. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax. 2008;63(1):53–59. doi:10.1136/thx.2006.069237
  • Kd Y, Nr P, S W. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J Immunol. 1989;143.
  • Fazekas G, Rosenwirth B, Dukor P, Gergely J, Rajnavölgyi É. Kinetics and isotype profile of rheumatoid factor production during viral infection: organ distribution of antibody secreting cells. Scand J Immunol. 1996;44(3):273–284. doi:10.1046/j.1365-3083.1996.d01-307.x
  • Pascolini S, Vannini A, Deleonardi G, et al. COVID-19 and immunological dysregulation: can autoantibodies be useful? Clin Transl Sci. 2021;14(2):502–508. doi:10.1111/cts.12908
  • Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155–162. doi:10.1097/BOR.0000000000000776
  • Halpert G, Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun Rev. 2020;19(12):102695. doi:10.1016/j.autrev.2020.102695
  • Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480. doi:10.1016/j.clim.2020.108480